pd 173074 has been researched along with Skin Neoplasms in 1 studies
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveras-Ferraros, C | 1 |
| Cufí, S | 1 |
| Queralt, B | 1 |
| Vazquez-Martin, A | 1 |
| Martin-Castillo, B | 1 |
| de Llorens, R | 1 |
| Bosch-Barrera, J | 1 |
| Brunet, J | 1 |
| Menendez, JA | 1 |
1 other study available for pd 173074 and Skin Neoplasms
| Article | Year |
|---|---|
Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Topics: Amphiregulin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apop | 2012 |